Skip to main navigation Skip to search Skip to main content

Survivorship of modern total hip replacement to 30 years: systematic review, meta-analysis, and extrapolation of global joint registry data

Veronica Pentland, Zoe Thompson, Alimu Dayimu, Nikos Demiris, Eric Bohm, David Campbell, Erik Lenguerrand, Anne Marie Fenstad, Ove Nord Furnes, Nils Hailer, Gaeme Hoit, Johan Kärrholm, Torbjørn Berge Kristensen, Keijo Mäkelä, Søren Overgaard, Elizabeth Paxton, Heather Prentice, Bheeshma Ravi, Mike Reed, Ola RolfsonClaus Varnum, Tommi Viitanen, James P. Waddell, Michael Whitehouse, Amir Khoshbin, Amit Atrey*

*Corresponding author for this work
1 Citation (Scopus)

Abstract

Background Total hip replacement is a successful operation that aims to restore function and quality of life to millions of people globally. Knowing how long a total hip replacement might last is important for patients, surgeons, and health-care institutions for planning and resource allocation. Over the past 20 years, the use of contemporary bearing surfaces for total hip replacement has substantially altered implant wear and, possibly, longevity. To date, there has been no large-scale study that examines survivorship of these modern implants. We aimed to determine the survivorship of contemporary total hip replacements and bearing materials. Methods We focused solely on the assessment of modern bearing surfaces: highly cross-linked polyethylene versus metal or third-generation and fourth-generation ceramic heads and ceramic-on-ceramic primary total hip replacement in adult patients. We conducted a search of MEDLINE and Embase from database inception to June 13, 2024, including articles that reported a minimum of 10 years of survivorship, irrespective of fixation method or surgical approach. We then conducted a meta-analysis combining data from eight national joint registries assessing all-cause revision within the various bearing combinations. We extrapolated the extracted data to estimate survivorship to 30 years, using the multivariable random-effects model from the registry data. The primary outcome was survivorship of the hip replacement, defined as time from primary total hip replacement to first all-cause revision, expressed as a percentage of unrevised implants at specific timepoints. This study is registered with PROSPERO (CRD42024572518). Findings We identified 1 904 237 total hip arthroplasties across 29 clinical studies (n=5203) and eight national joint registries (n=1 899 034). Pooled analysis of the included studies showed an all-cause implant survivorship of 0·97 (0·96–0·98) under the random-effects model. Survivorship estimate based on joint registry data was at 93·6% (95% CI 92·3–94·7) at 20 years. Extrapolating these data indicates a predicted survivorship of 92·8% (91·2–94·2) at 25 years and 92·1% (90·1– 93·7) at 30 years. Interpretation The estimated 92% 30-year survivorship of contemporary total hip replacement suggests that advances in bearing surface technology have greatly improved the long-term durability of total hip replacements and might influence patient counselling, health-care planning, and device regulation. Funding None.

Original languageEnglish
JournalThe Lancet
Volume407
Issue number10531
Pages (from-to)855-866
Number of pages12
ISSN0140-6736
DOIs
Publication statusPublished - 28 Feb 2026

Fingerprint

Dive into the research topics of 'Survivorship of modern total hip replacement to 30 years: systematic review, meta-analysis, and extrapolation of global joint registry data'. Together they form a unique fingerprint.

Cite this